Single her2-positive tumor cells are detected in initially her2-negative breast carcinomas using the deparray™-her2-fish workflow

HIGHLIGHTS

• who: Lisa Grüntkemeier from the Department of Gynecology and Obstetrics, University Hospital Essen, Hufelandstrasse, Essen, Germany have published the research: Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™-HER2-FISH workflow, in the Journal: (JOURNAL)
• what: In a second step, the authors aimed to evaluate BC intra-tumor heterogeneity using the DEPArray™-HER2-FISH workflow in another 25 BC patients (development cohort) characterized as HER2-neg (DAKOScore 0 or + 1) on the PT but HER2/neu-pos on CTCs. The authors propose that HER2-equivocal BC . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.